BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 14607350)

  • 1. Effects of after-midnight intake of zolpidem and temazepam on driving ability in women with non-organic insomnia.
    Partinen M; Hirvonen K; Hublin C; Halavaara M; Hiltunen H
    Sleep Med; 2003 Nov; 4(6):553-61. PubMed ID: 14607350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next-day residual effects of hypnotics in DSM-IV primary insomnia: a driving simulator study with simultaneous electroencephalogram monitoring.
    Staner L; Ertlé S; Boeijinga P; Rinaudo G; Arnal MA; Muzet A; Luthringer R
    Psychopharmacology (Berl); 2005 Oct; 181(4):790-8. PubMed ID: 16025317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomised clinical trial of the effects of prolonged-release melatonin, temazepam and zolpidem on slow-wave activity during sleep in healthy people.
    Arbon EL; Knurowska M; Dijk DJ
    J Psychopharmacol; 2015 Jul; 29(7):764-76. PubMed ID: 25922426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highway driving in the elderly the morning after bedtime use of hypnotics: a comparison between temazepam 20 mg, zopiclone 7.5 mg, and placebo.
    Leufkens TR; Vermeeren A
    J Clin Psychopharmacol; 2009 Oct; 29(5):432-8. PubMed ID: 19745642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Residual effects of middle-of-the-night administration of zaleplon and zolpidem on driving ability, memory functions, and psychomotor performance.
    Verster JC; Volkerts ER; Schreuder AH; Eijken EJ; van Heuckelum JH; Veldhuijzen DS; Verbaten MN; Paty I; Darwish M; Danjou P; Patat A
    J Clin Psychopharmacol; 2002 Dec; 22(6):576-83. PubMed ID: 12454557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highway driving performance and cognitive functioning the morning after bedtime and middle-of-the-night use of gaboxadol, zopiclone and zolpidem.
    Leufkens TR; Lund JS; Vermeeren A
    J Sleep Res; 2009 Dec; 18(4):387-96. PubMed ID: 19552733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.
    Roth T; Soubrane C; Titeux L; Walsh JK;
    Sleep Med; 2006 Aug; 7(5):397-406. PubMed ID: 16815744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of prolonged-release melatonin, zolpidem, and their combination on psychomotor functions, memory recall, and driving skills in healthy middle aged and elderly volunteers.
    Otmani S; Demazières A; Staner C; Jacob N; Nir T; Zisapel N; Staner L
    Hum Psychopharmacol; 2008 Dec; 23(8):693-705. PubMed ID: 18763235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia.
    Scharf MB; Roth T; Vogel GW; Walsh JK
    J Clin Psychiatry; 1994 May; 55(5):192-9. PubMed ID: 8071269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zolpidem is not superior to temazepam with respect to rebound insomnia: a controlled study.
    Voshaar RC; van Balkom AJ; Zitman FG
    Eur Neuropsychopharmacol; 2004 Aug; 14(4):301-6. PubMed ID: 15163440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zolpidem, triazolam, and temazepam: behavioral and subject-rated effects in normal volunteers.
    Rush CR; Griffiths RR
    J Clin Psychopharmacol; 1996 Apr; 16(2):146-57. PubMed ID: 8690830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zolpidem in the treatment of transient insomnia: a double-blind, randomized comparison with placebo.
    Roth T; Roehrs T; Vogel G
    Sleep; 1995 May; 18(4):246-51. PubMed ID: 7618022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of zolpidem on cyclic alternating pattern, an objective marker of sleep instability, in Japanese patients with psychophysiological insomnia: a randomized crossover comparative study with placebo.
    Ozone M; Yagi T; Itoh H; Tamura Y; Inoue Y; Uchimura N; Sasaki M; Shimizu T; Terzano MG; Parrino L
    Pharmacopsychiatry; 2008 May; 41(3):106-14. PubMed ID: 18484552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Residual effects of low-dose sublingual zolpidem on highway driving performance the morning after middle-of-the-night use.
    Vermeeren A; Vuurman EF; Leufkens TR; Van Leeuwen CJ; Van Oers AC; Laska E; Rico S; Steinberg F; Roth T
    Sleep; 2014 Mar; 37(3):489-96. PubMed ID: 24587571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects on postural oscillation and memory functions of a single dose of zolpidem 5 mg, zopiclone 3.75 mg and lormetazepam 1 mg in elderly healthy subjects. A randomized, cross-over, double-blind study versus placebo.
    Allain H; Bentué-Ferrer D; Tarral A; Gandon JM
    Eur J Clin Pharmacol; 2003 Jul; 59(3):179-88. PubMed ID: 12756510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of zolpidem on sleep in women with perimenopausal and postmenopausal insomnia: a 4-week, randomized, multicenter, double-blind, placebo-controlled study.
    Dorsey CM; Lee KA; Scharf MB
    Clin Ther; 2004 Oct; 26(10):1578-86. PubMed ID: 15598474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind placebo-controlled trial of zopiclone 7.5 mg and temazepam 20 mg in insomnia.
    Ngen CC; Hassan R
    Int Clin Psychopharmacol; 1990 Jul; 5(3):165-71. PubMed ID: 2230060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preference of insomniac patients between a single dose of zolpidem 10 mg versus zaleplon 10 mg.
    Allain H; Bentué-Ferrer D; Breton SL; Polard E; Gandon JM
    Hum Psychopharmacol; 2003 Jul; 18(5):369-74. PubMed ID: 12858323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of repeated administration of zolpidem on sleep, diurnal and nocturnal respiratory function, vigilance, and physical performance in patients with COPD.
    Girault C; Muir JF; Mihaltan F; Borderies P; De La Giclais B; Verdure A; Samson-Dollfus D
    Chest; 1996 Nov; 110(5):1203-11. PubMed ID: 8915222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute effects of zolpidem on daytime alertness, psychomotor and physical performance.
    Ito SU; Kanbayashi T; Takemura T; Kondo H; Inomata S; Szilagyi G; Shimizu T; Nishino S
    Neurosci Res; 2007 Nov; 59(3):309-13. PubMed ID: 17825448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.